Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Dietary L-serine supplementation can reduce symptoms of HSAN1 by lowering harmful 1-deoxySL levels.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

SCD1 inhibitors can cause skin issues in rodents.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

GLP-1 agonists may help treat certain skin conditions.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

Sdr16c5 and Sdr16c6 genes regulate a key point in lipid production that affects eye and skin gland function.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.